William Smith

Jan 11, 2025 | townhall.com | William Smith

China and the U.S. are in a race for preeminence in biotechnology. The U.S. is still dominant in biology and life sciences research, but China is catching up fast. At the same time, Congress and the Biden administration have enacted such severe anti-biopharmaceutical policies that China seems likely to win this race. The incoming Trump administration has an opportunity to rectify these policies and secure America’s longstanding leadership in the biotechnology sector.

Oct 22, 2024 | yourvalley.net | William Smith

Posted Tuesday, October 22, 2024 10:07 am William Smith | Fountain Hills I’ve read several articles about voting “blue” and expressing confusion why anyone would vote for Trump. There are many reasons to vote for Trump, most important is the wallet, one that can comfortably feed, shelter and clothe my family. Compared to Biden/Harris, Trump delivered a much more affordable cost of living with reasonable costs, tolerable inflation and a better family life with a few extra bucks to have fun was...

Sep 24, 2024 | townhall.com | William Smith

The federal government recently announced the actual prices on the first 10 drugs subject to price caps created by the Inflation Reduction Act (IRA) for the Medicare program. According to the Biden administration, these 10 drugs have cost Medicare approximately $50 billion, or about 20 percent of Medicare drug spending. With these price caps, the administration estimates that Medicare will save $6 billion.

Sep 9, 2024 | detroitnews.com | William Smith |Robert Popovian

William Smith and Robert Popovian |  The Detroit NewsThe federal 340B Drug Pricing Program was designed to encourage hospitals and clinics to provide low-income patients with more charity care. Today, the program costs taxpayers billions of dollars. Still, there is far more evidence that hospitals are using the money to subsidize unrelated operations than helping those in need. There is an aphorism that says if you are going to say something deceptive, go big.

Nov 20, 2023 | mackinac.org | Jarrett Skorup |William Smith

President Biden is proud of his price controls. Federally dictated prices for prescription drugs are “a key part of Bidenomics,” according to the President. Yet these top-down mandates are already killing research into life-saving cures, and by one count, at least 135 new drugs will never come to market, including many cancer drugs. And now states may soon double down on this failed approach, capping the price of drugs in ways that hurt patients.